Lexapro (Escitalopram) 20 mg Side Effects
Lexapro 20 mg causes common side effects including nausea (15%), insomnia (9-14%), sexual dysfunction (9-14% in males, 2-6% in females), diarrhea (8-14%), and fatigue (5-8%), with serious but rare risks including suicidal thoughts in young adults, serotonin syndrome, and abnormal bleeding. 1
Common Side Effects (Occurring in ≥2% of Patients)
Gastrointestinal Effects
- Nausea is the most common side effect, occurring in 15% of patients taking escitalopram compared to 7% with placebo 1
- Diarrhea occurs in 8-14% of patients (dose-dependent, with higher rates at 20 mg) 1
- Constipation affects 3-6% of patients 1
- Dry mouth, indigestion, abdominal pain, and vomiting each occur in 2-3% of patients 1
Sexual Dysfunction
- Ejaculatory delay or disorder occurs in 9-14% of males (significantly higher at 20 mg dose) 1
- Decreased libido affects 3-7% of patients 1
- Anorgasmia occurs in 2-6% of females 1
- Impotence affects 3% of males 1
- Sexual dysfunction may persist after discontinuation in rare cases, though this is not well-quantified 2
Neuropsychiatric Effects
- Insomnia occurs in 9-14% of patients (dose-dependent, with 14% at 20 mg versus 7% at 10 mg) 1
- Somnolence affects 6-9% of patients 1
- Dizziness occurs in 5-7% of patients 1
- Fatigue affects 5-8% of patients 1
Other Common Effects
- Increased sweating occurs in up to 8% of patients at 20 mg 1
- Decreased appetite affects 3% of patients 1
- Influenza-like symptoms occur in 5% of patients 1
- Rhinitis and sinusitis each affect 3-5% of patients 1
Serious Side Effects Requiring Immediate Medical Attention
Suicidal Thoughts and Behavior
- Increased risk of suicidal thoughts or actions in children, teenagers, and young adults under 25 years, particularly within the first few months of treatment or with dose changes 1
- Monitor for new or worsening depression, anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, or suicidal ideation 1
Serotonin Syndrome
- Life-threatening condition that can occur, especially when combined with other serotonergic medications 1
- Symptoms include agitation, hallucinations, confusion, racing heartbeat, high or low blood pressure, sweating, fever, muscle rigidity, coordination problems, nausea, vomiting, and diarrhea 1
Bleeding Risk
- Escitalopram increases risk of abnormal bleeding or bruising, particularly when combined with warfarin, NSAIDs, or aspirin 1
- Gastrointestinal bleeding risk has an odds ratio of 1.2-1.5, with higher risk when combined with antiplatelet or NSAID therapy 3
Cardiovascular Effects
- QT prolongation is dose-dependent; FDA issued a 2012 boxed warning not to exceed 40 mg daily (or 20 mg daily in adults over 60 years) 3
- Escitalopram, along with citalopram and amitriptyline, carries risk for QT prolongation 3
Hyponatremia
- Occurs in 0.5-12% of older adults 3
- Odds ratio of 3.3 for SSRIs compared with other antidepressant classes 3
- Typically occurs within the first month of treatment 3
- Symptoms include headache, weakness, confusion, problems concentrating, and memory problems 1
- Elderly patients are at greater risk 1
Other Serious Effects
- Seizures or convulsions can occur 1
- Manic episodes (greatly increased energy, severe insomnia, racing thoughts, reckless behavior, excessive happiness or irritability) 1
- Severe allergic reactions including trouble breathing, facial swelling, rash, or hives 1
- Visual problems including eye pain, vision changes, or eye swelling (angle-closure glaucoma risk) 1
- Hepatotoxicity: 0.5-3% will have asymptomatic mild transaminase elevation, typically within 6 months 3
Dose-Dependent Side Effects
The 20 mg dose shows approximately twice the incidence of several side effects compared to 10 mg: 1
- Insomnia: 14% at 20 mg versus 7% at 10 mg
- Diarrhea: 14% at 20 mg versus 6% at 10 mg
- Dry mouth: 9% at 20 mg versus 4% at 10 mg
- Somnolence: 9% at 20 mg versus 4% at 10 mg
- Dizziness: 7% at 20 mg versus 4% at 10 mg
- Increased sweating: 8% at 20 mg versus 3% at 10 mg
Discontinuation Symptoms
Stopping escitalopram abruptly can cause withdrawal symptoms including: 1
- Anxiety, irritability, mood changes, restlessness
- Headache, sweating, nausea, dizziness
- Electric shock-like sensations, shaking, confusion
- Sleep disturbances
Special Populations
Pregnancy
- Late pregnancy use may increase risk of neonatal complications 1
- Patients should discuss risks versus benefits with their healthcare provider 1
Breastfeeding
- Escitalopram passes into breast milk 1
- Discussion with healthcare provider recommended regarding infant feeding 1
Clinical Considerations
Escitalopram demonstrates linear pharmacokinetics with steady-state achieved within 7-10 days, has low protein binding (56%), and minimal cytochrome P450 interactions 4
The drug is generally well-tolerated with a low discontinuation rate due to adverse events, showing no statistically significant difference from placebo in discontinuation rates at 10 mg daily 5
Weight changes are not clinically significant with escitalopram treatment in controlled trials 1